![](https://endpts.com/wp-content/uploads/2021/07/Howard-Liang-scaled.jpg)
Howard Liang, Tessera CFO
Tessera Therapeutics taps former BeiGene CFO Howard Liang to join race to CRISPR 3.0
A day after Prime Medicines emerged from semi-stealth with new CRISPR tech that made even venture capitalist Bob Nelsen say “holy crap,” a Cambridge …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.